These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26324773)

  • 1. IL-7 Abrogates the Immunosuppressive Function of Human Double-Negative T Cells by Activating Akt/mTOR Signaling.
    Allgäuer A; Schreiner E; Ferrazzi F; Ekici AB; Gerbitz A; Mackensen A; Völkl S
    J Immunol; 2015 Oct; 195(7):3139-48. PubMed ID: 26324773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity.
    Haug T; Aigner M; Peuser MM; Strobl CD; Hildner K; Mougiakakos D; Bruns H; Mackensen A; Völkl S
    Front Immunol; 2019; 10():883. PubMed ID: 31105702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells.
    Voelkl S; Gary R; Mackensen A
    Eur J Immunol; 2011 Mar; 41(3):739-48. PubMed ID: 21287552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
    Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
    J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
    Völkl S; Rensing-Ehl A; Allgäuer A; Schreiner E; Lorenz MR; Rohr J; Klemann C; Fuchs I; Schuster V; von Bueren AO; Naumann-Bartsch N; Gambineri E; Siepermann K; Kobbe R; Nathrath M; Arkwright PD; Miano M; Stachel KD; Metzler M; Schwarz K; Kremer AN; Speckmann C; Ehl S; Mackensen A
    Blood; 2016 Jul; 128(2):227-38. PubMed ID: 27099149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation.
    Ahmed RK; Poiret T; Ambati A; Rane L; Remberger M; Omazic B; Vudattu NK; Winiarski J; Ernberg I; Axelsson-Robertson R; Magalhaes I; Castelli C; Ringden O; Maeurer M
    J Immunother; 2014 Oct; 37(8):416-25. PubMed ID: 25198529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.
    Nguyen TP; Bazdar DA; Mudd JC; Lederman MM; Harding CV; Hardy GA; Sieg SF
    J Leukoc Biol; 2015 Jun; 97(6):1139-46. PubMed ID: 25784743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation.
    McIver Z; Serio B; Dunbar A; O'Keefe CL; Powers J; Wlodarski M; Jin T; Sobecks R; Bolwell B; Maciejewski JP
    Br J Haematol; 2008 Apr; 141(2):170-8. PubMed ID: 18318770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of IL-6-signaling inhibits the pathogenesis of CD4+ T cell-mediated lethal graft-versus-host reaction against minor histocompatibility antigen.
    Noguchi D; Wakita D; Ohkuri T; Tajima M; Chamoto K; Kitamura H; Nishimura T
    Immunol Lett; 2011 May; 136(2):146-55. PubMed ID: 21256159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
    Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
    Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD3+CD4-CD8- (double negative) T cells reconstitution in patients following hematopoietic stem-cell transplantation.
    Ye H; Chang Y; Zhao X; Huang X
    Transpl Immunol; 2011 Dec; 25(4):180-6. PubMed ID: 21911061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
    Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation.
    Gigoux M; Lovato A; Leconte J; Leung J; Sonenberg N; Suh WK
    Mol Immunol; 2014 May; 59(1):46-54. PubMed ID: 24486724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
    Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
    J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.